Literature DB >> 17823983

Type I interferon regulates pDC maturation and Ly49Q expression.

Makiko Toma-Hirano1, Sahori Namiki, Shoichiro Miyatake, Ken-Ichi Arai, Yumiko Kamogawa-Schifter.   

Abstract

Ly49Q is expressed on peripheral mouse plasmacytoid dendritic cells (pDC). Immature Ly49Q-negative pDC precursors acquire Ly49Q in the bone marrow and then migrate into the periphery. While searching for molecules that regulate pDC maturation, we found that type I interferon (IFN) inhibited Ly49Q acquisition in vitro. Infections that induce type I IFN production by cells other than pDC (a condition mimicked by poly(I:C) injection in vivo) increase the prevalence of Ly49Q(-) pDC in the bone marrow and peripheral lymphoid organs in wild-type but not IFN-alpha/beta receptor knockout BALB/c mice. Moreover, in vivo exposure to type I IFN causes some Ly49Q(-), but not Ly49Q(+), pDC to convert to conventional DC, defined as B220(-) CD11c(+) CD11b(+) cells. These data suggest that type I IFN regulates pDC development and affects their distribution in the body.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823983     DOI: 10.1002/eji.200737173

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

Review 1.  Role of dendritic cell subsets in immunity and their contribution to noninfectious uveitis.

Authors:  Ping Chen; Alastair K Denniston; Sima Hirani; Susan Hannes; Robert B Nussenblatt
Journal:  Surv Ophthalmol       Date:  2015-01-28       Impact factor: 6.048

2.  Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.

Authors:  Zoe Waibler; Martina Anzaghe; Theresa Frenz; Astrid Schwantes; Christopher Pöhlmann; Holger Ludwig; Marcos Palomo-Otero; Antonio Alcamí; Gerd Sutter; Ulrich Kalinke
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

3.  Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease.

Authors:  Hemant Agrawal; Noam Jacob; Esther Carreras; Sandra Bajana; Chaim Putterman; Sean Turner; Barbara Neas; Alexis Mathian; Michael N Koss; William Stohl; Susan Kovats; Chaim O Jacob
Journal:  J Immunol       Date:  2009-10-07       Impact factor: 5.422

4.  In vivo conversion of BM plasmacytoid DC into CD11b+ conventional DC during virus infection.

Authors:  Li-Ying Liou; Amanda L Blasius; Megan J Welch; Marco Colonna; Michael B A Oldstone; Elina I Zuniga
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 5.532

5.  Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome.

Authors:  Naoki Takemura; Takumi Kawasaki; Jun Kunisawa; Shintaro Sato; Aayam Lamichhane; Kouji Kobiyama; Taiki Aoshi; Junichi Ito; Kenji Mizuguchi; Thangaraj Karuppuchamy; Kouta Matsunaga; Shoichiro Miyatake; Nobuko Mori; Tohru Tsujimura; Takashi Satoh; Yutaro Kumagai; Taro Kawai; Daron M Standley; Ken J Ishii; Hiroshi Kiyono; Shizuo Akira; Satoshi Uematsu
Journal:  Nat Commun       Date:  2014-03-18       Impact factor: 14.919

Review 6.  Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation.

Authors:  Dimitry A Chistiakov; Alexander N Orekhov; Igor A Sobenin; Yuri V Bobryshev
Journal:  Front Physiol       Date:  2014-07-25       Impact factor: 4.566

7.  Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus.

Authors:  Hannah Phipps-Yonas; Jeremy Seto; Stuart C Sealfon; Thomas M Moran; Ana Fernandez-Sesma
Journal:  PLoS Pathog       Date:  2008-10-31       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.